Old Web
English
Sign In
Acemap
>
authorDetail
>
John Brejda
John Brejda
Pharmacology
Pharmacokinetics
Medicine
Raltegravir
Dosing
5
Papers
57
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects
2017
Clinical Drug Investigation
Ka Lai Yee
Sauzanne Khalilieh
Rosa I. Sanchez
Rachael Liu
Matt S. Anderson
Helen Manthos
Timothy Judge
John Brejda
Joan R. Butterton
Show All
Source
Cite
Save
Citations (31)
Efavirenz does not meaningfully affect the single dose pharmacokinetics of 1200 mg raltegravir
2016
Biopharmaceutics & Drug Disposition
Rajesh Krishna
Lilly East
Patrick Larson
Tara Siringhaus
Lisa Herpok
Crystal Bethel‐Brown
Helen Manthos
John Brejda
Michael Gartner
Show All
Source
Cite
Save
Citations (5)
Atazanavir increases the plasma concentrations of 1200 mg raltegravir dose
2016
Biopharmaceutics & Drug Disposition
Rajesh Krishna
Lilly East
Patrick Larson
Chandni Valiathan
Kathleen Deschamps
Julie Ann Luk
Crystal Bethel‐Brown
Helen Manthos
John Brejda
Michael Gartner
Show All
Source
Cite
Save
Citations (7)
P0910 : No evidence of pharmacokinetic drug–drug interaction in healthy subjects between coadministered grazoprevir (MK-5172)/elbasvir (MK-8742) and sofosbuvir
2015
Journal of Hepatology
William L. Marshall
Wendy W. Yeh
Daria Stypinski
Patrice Auger
C. Bethel-Brown
Luzelena Caro
Patricia Jumes
Xiaobi Huang
Zifang Guo
Monika Martinho
Hwa-Ping Feng
D. Armas
John Brejda
Marian Iwamoto
Joan R. Butterton
Show All
Source
Cite
Save
Citations (2)
A multicenter study of nutraceutical drinks for cholesterol (evaluating effectiveness and tolerability)
2012
Journal of Clinical Lipidology
Mitchell Karl
Mark Rubenstein
Chad Rudnick
John Brejda
Show All
Source
Cite
Save
Citations (12)
1